European Heart Journal

Article	Citations
Meet the European Society of Cardiology Gold Medallists 2022	4133
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	3301
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	2571
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	2497
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	2280
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	2260
Pulmonary haemodynamics and pulmonary congestion: where are we now?	2237
A rare case of a dorsal mass caused by descending thoracic aortic dissection	2018
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	1846
Intricacies of aortic risk assessment studies: not a simple matter	1465
Bulgarian Society of Cardiology: 50 years on	1293
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	1140
Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	934
Weekly Journal Scan: The promise of small interfering RNA in reducing lipoprotein(a)	793
Dementia in individuals with severe hypercholesterolemia: Korean nationwide cohort study	672
Recent cardiac rehabilitation and its impact on cardiopulmonary exercise test variables in Brazilian cardiac transplant recipients	566
Differences in left atrial stain, endothelial glycocalyx, arterial elasticity and myocardial efficiency between ESUS, lacunar, cardioembolic and atherosclerotic type of stroke	455
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry	420
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism	323
Multiparametric risk predictions for morbidity and mortality in patients with pulmonary arterial hypertension: insights from a nation-wide registry	317
Cardiac troponin fragmentation in marathon runners. The MaraCat2 study	309
Echocaridographic assessment of pulmonary hypertension: improving the probability	307
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease	300
Physiological disease pattern as assessed by PPGI in vessels with FFR and iFR discordance	295
Cumulative accelerometer-based light physical activity from childhood through young adulthood progressively decreases left ventricular mass in British youth: a 13-year longitudinal study	270

Novel cardiovascular magnetic resonance imaging heterogeneity biomarkers to diagnose and predict cardiovascular disease: a UK Biobank CMR strain study	270
Clinical outcomes of deferred lesions by IVUS versus FFR-guided treatment decision: the FLAVOUR trial substudy	270
T regulatory cells lose their protective phenotype in patients with coronary artery disease (CAD)	256
Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes	247
Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions	237
Association between the changes in walking speed during 6 months after discharge and subsequent prognosis in older patients with heart failure: report from a multicenter prospective cohort study	225
New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)	224
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team	219
Deep learning for fully automated echocardiographic measurements of left ventricular wall thickness and chamber dimensions in the parasternal long-axis view	211
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	208
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	206
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	203
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	199
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	197
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching	196
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	196
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function	186
Implementing dynamic atrioventricular delay optimization for cardiac resynchronization therapy: an economic analysis in the EU5 countries	183
Practicing what you preach. Do cardiology trainees in the United Kingdom follow the lifestyle advice that they would give to patients?	179
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	176
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	174
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	173
Factors for incorrect automated atrial fibrillation identification in large-scale screening	165
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	159
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	158
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study	156
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure	155
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report	155
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	153
Quantitative assessment of myocardial fibrosis by digital image analysis: an adjunctive tool for pathologist ground truth	152
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study	151
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	151
Impact of the thin-walled sheath on the distal radial artery occlusion: a randomized trial	149
Prognostic role of data transmitted by implanted cardiac electric devices in patients with advanced heart failure referred for heart transplantation	148
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	148
The role of seasonal influenza immunisation in cardiovascular care: a survey of cardiologists	143
Comparative study of the effects of left ventricular and biventricular pacing on indices of cardiac function and clinical status of heart failure patients: preliminary results of READAPT study	143
Ultra-processed food consumption and risk of cardiovascular mortality in Australia: preliminary results from prospective observational study	142
Dynamic changes of excessive trabeculation in dilated cardiomyopathy: a longitudinal cardiovascular magnetic resonance study	141
Acute deterioration in dyssynchrony and systolic function from Lot-CRT to LBBB pacing	141
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarction	133
Comparison of fully angiography-derived versus a hybrid of angiography and pressure-wire-derived approach to assess coronary microvascular resistance: the OxAMI-Hybrid study	133
The added value of advanced echocardiography in dilated cardiomyopathy: looking at the right heart	132
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study	131
Trimethylamine N-oxide as a Novel Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling in ST-Elevation Myocardial Infarction Patients	131
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain	131
Endothelial dysfunction in acute coronary syndrome: a complex association with cardiovascular risk factors, sleep quality and cardiorespiratory capacity	130
Survival in STEMI in resource limited settings - obstacles and potential solutions. Critical lesson learnt thorough a prospective observational study	127
Long-term outcomes following DCB vs. DES for ISR treatment	127
Associated factors and clinical implications of dynamic changes in late gadolinium enhancement after acute myocarditis	127

Feasibility and efficacy of a novel 6 french sheathless guiding catheter equipped with peel-off type external dilator for PCI with distal radial approach - a Japanese multicenter study	127
Plaque phenotyping using deep learning in optical coherence tomography imaging	124
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation	123
Ischemic stroke in patients with congenital heart disease and atrial fibrillation	122
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography	122
Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study	121
NOAC in adult congenital heart disease patients: a single-center experience	120
Prognostic value of cardiac magnetic resonance in elderly patients soon after ST-segment elevation myocardial infarction	118
Usefulness of CineECG method in identification of P-wave morphology variants in an elderly epidemiologic cohort	117
Echocardiography in acute pulmonary embolism for the prediction of subsequent CTEPH	116
Phenotyping of heart failure with preserved ejection faction using health electronic records and echocardiography	115
Impaired right ventricular strain is associated with worse prognosis in patients with liver cirrhosis	114
The specificity of cardiac troponin elevations for myocardial infarction declines with age	114
Phenotyping coronary plaque by computed tomography in premature coronary artery disease	114
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention	114
How can the detection of AF be improved? Insights from patient journeys and primary care clinicians	113
The impact of worsening heart failure (WHF) status on subsequent outcomes among patients with HFrEF: History of WHF events is associated with worse subsequent outcomes regardless of extent of GDMT	113
Discovering an unknown risk. The unnoticed, potientially life-threatening risk to people with an inherited cardaic arrhythmia during the non-cardiac perioperative period.	113
Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions	113
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study	111
Safety of electrophysiological study in atrioventricular block risk stratification in new-onset persistent left bundle brunch block following transcathether aortic valve implantation	108
Prediction of outcome in malignant hypertension patients using machine learning: a report from the West Birmingham malignant hypertension registry	108
Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease	107
Artificial intelligence-assisted examination of cardiac health status through electrocardiogram	107
Quantifying cardiac tissue heterogeneity using high-density grid catheter: validation in porcine model	106
Cardiovascular etiologies and risk factors of survival outcomes after resuscitation for out-of-hospital cardiac arrest: data from the KoCARC registry	106
A larger reduction of spatial mean QRS-T angle during cardiac resynchronisation therapy is associated with a lower risk of mortality and heart failure hospitalisation	106
Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial	105
Blood pressure polygenic risk scores associate with resistant hypertension in individuals with type 1 diabetes	105
Calculation of intraprocedural hemodynamics with computational functional dynamic in mitral valve edge-to-edge repair	103
Is left atrial reservoir strain a superior modality to predict acute left ventricular failure in hypertensive patients	102
Further prognostic stratification in patients with oscillatory ventilation with exercise: is there more to it than just ups and downs?	102
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice	101
Mortality and predictors of death in women and men with congestive heart failure of different types of cardiomyopathies	101
Association between quantitative flow ratio and non-target-vessel-related events before planned staged percutaneous coronary intervention in patients with acute coronary syndrome	99
ARNI effects in HFrEF. Risk reduction beyond LVEF	99
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period	98
Cardiometabolic outcomes in patients with overweight and obesity undergoing weight loss trials : a network meta-analysis	98
Reduced 3D-left atrium ejection fraction predicts development of atrial fibrillation in patients with hypertrophic cardiomyopathy	97
Microtransesophageal echocardiographic guidance of patent foramen ovale percutaneous closure	96
Prognostic role of early cardiac magnetic resonance in myocardial infarction with non-obstructive coronary arteries	96
Sacubitril-valsartan activates pAMPK and reduces NLRP3, MyD88, cytokines/growth factors and DAMPs in doxorubicin-treated mice improving longitudinal strain and ejection fraction	95
Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation	95
Influence of radiotherapy on cardiac implantable device lead parameters	95
Ten years survival benefit of CABG or PCI based on individual prediction	94
Machine learning can accurately detect abnormal aortic valves in CMR	94
Lipoprotein(a) and cardiovascular prognosis of familial dyslipidemias: data from a 10-year follow-up study	94
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: design, rationale, and first results of the Zabrze-Lip(a)R Registry	93
Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm	93
Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry	92
Machine learning model using cardiovascular magnetic resonance to predict cardiovascular events in asymptomatic patients with known CAD	92
Microvascular dysfunction and absolute coronary blood flow after percutaneous coronary intervention of a chronic total occlusion	92
Left atrial function and long-term survival after cardiac resynchronization therapy	92
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation: observations from the GARFIELD-AF registry	91
Effect of sacubitril/valsartan and empagliflozin on systemic inflammation and scar remodeling in a swine model of myocardial infarction	91
Variations in atrial fibrillation screening after ischemic stroke or transient ischemic attack in Sweden	90
Combined cardiopulmonary test and exercise Doppler echocardiography in systemic sclerosis	90
Characterisation of metabolic phenotype in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study	89
MINOCA due to vasospasm compared to other mechanisms: patients characteristics, evolution and prognosis	89
How to predict myocardial injury in patients with large ischaemic burden identified during stress echocardiography?	88
Primary care screening and prevention of heart failure coordinated by cardiologist in rural areas	88
Pulmonary artery aneurysm in pulmonary arterial hypertension associated with congenital heart disease	87
Targeting Neurofibromin 2 (NF2) prevents endothelial dysfunction in obesity: a study in mice and humans	87
The impact of hydrostatic pressure on fractional flow reserve in saphenous vein grafts	86
Anticoagulation and stroke in hospitalized patients newly diagnosed with secondary atrial fibrillation: a population-based cohort study	85
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study	84
Efficacy of controlvit as a complementary strategy in reducing hospitalizations in patients with heart failure. Randomized clinical trial	84
Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease	84
Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS	84
Early quantitative pupillary response parameters have high predictive value for 30-day mortality in patients resuscitated from out-of-hospital cardiac arrest	84
Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: insights From the IMPEDANCE-HF Trial	83
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry	83
A novel technology for heart failure that utilizes the respiratory effort to shift fluids from the lung and alleviate cardiac workloads; feasibility study in sheep	83
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction	82
Differential efficacy and safety of oral anticoagulation in atrial fibrillation patients with or without comorbid vascular disease: insights from the GARFIELD-AF registry	82
Demographic, clinical characteristics, managements strategies and in-hospital outcomes of patients enrolled in prospective nationwide SCAD registry	82
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study	81
Ultrasonographic and functional evaluation of forearm circulation with occluded radial artery	81
Various arrhythmia types and their day-by-day occurrence rates over a 14-day period using a P-wave sensitive ambulatory ECG monitored population	81
Heavy weekly alcohol consumption versus binge drinking after an acute coronary syndrome and risk of major adverse cardiovascular events at one year follow up	80

Estimation of antihypertensive effect after initiating continuous positive airway pressure treatment in Japanese patients with sleep disordered breathing	80
Safety and efficacy of cerebral embolic protection devices in transcatheter aortic valve implantation: a meta-analysis	79
Ethnic disparity in the care and management of non-ST-segment elevation myocardial infarction and its impact on short-term and long-term survival: a long-term study of a national registry	79
Biomarker profiles of favorable ventricular remodeling in heart failure patients with reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial	79
Sequential left ventricular electro-mechanical changes in left bundle branch pacing vs right ventricular pacing a two-center study	78
Participation of epicardial connection in transverse conduction across the crista terminalis in patients with upper and lower loop reentry atrial tachycardias	77
COVID-19 vaccination in the pediatric age and risk for myocarditis	76
Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes	76
Guideline-directed medical therapy and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction	75
Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy	74
Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis	74
Figuring out complete left ventricular reverse remodeling in tachycardiomyopathy	74
Afterload mismatch is associated with gender mismatch and negatively affect long-term outcome after heart transplant	74
Reduction of triglyceride-rich lipoproteins with retatrutide in type 2 diabetes may be explained by concurrent reduction in ANGPTL3/8 levels	73
Routine use of 3-dimensional zoom modality with 2-dimensional transesophageal echocardiography to decide the candidacy for transcatheter device closure of atrial septal defect	73
Computed tomography plaque analysis identifies residual inflammation in recent acute myocardial infarction patients	72
Bipolar ablation of refractory ventricular arrhythmias using a novel dedicated adapter. A multicenter study	72
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in CFA-challenged albino mice	71
Influence of lead extraction on tricuspid valve function	71
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry	71
Infective endocarditis - characteristics and long-term outcomes in patients with congenital heart disease are distinct from those without congenital heart disease	70
Cardiac complications as a major predictor of in-hospital death in infective endocarditis using machine-learning algorithm analysis	70
Allied health professional-physician collaboration to enhance guideline-directed medical therapy of heart failure: expanding therapeutic opportunities	70
Epidemiology, clinical characterization, and outcomes for heart failure with improved ejection fraction	70
Functinal assessment in Angina and Non-Obstructive Coronary Arteries (ANOCA) patients: from Microvascular Resistance Reserve (MRR) to different subtypes of Coronary Microvascular Dysfunction (CMD)	69
Interaction of inherited genetic variants in the NLRP3 inflammasome/IL-6 pathway with acquired clonal hematopoiesis to modulate mortality risk in patients with HFrEF	69
Coronary rotational atherectomy in patients with severe aortic stenosis	69
High-sensitivity C-reactive protein is associated with cardiac dysfunction and morbidity in a community-based cohort	69
Artificial intelligence as a precision tool for predicting risk of in-hospital death after aortic valve replacement	69
Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: a systematic review and meta-analysis of 38 studies	68
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis	68
Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017	68
Refining the prognosis of patients with AF using 3D transesophageal echocardiography of the left atrial appendage	68
Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)	68
Telomere length across spectrum of metabolic health	68
Heart failure therapy in new onset heart failure versus chronic heart failure: an analysis of 90,383 patients from the Swedish Heart Failure Registry (SwedeHF)	67
Cardiac troponin T and I are differentially associated with myocardial fibrosis assessed by cardiac magnetic resonance imaging	67
Strategic management to optimize response to cardiac resynchronization therapy registry	67
Beyond secondary prevention drugs: added benefit in survival and events of a healthy lifestyle in patients after an acute coronary syndrome	67
The correlation between angio-IMR and thermodilution-based IMR in patients with ischemia and non obstructive coronary arteries	67
Prognostic impact of echocardiographic derived precapillary wedge pressure and pulmonary vascular resistances in patients with heart failure	66
Disparities in the access to atrial fibrillation ablation in Denmark	66
Automated non-invasive quantification of myocardial work using 3D echocardiography and validation with invasive catheter measurements	66
Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement	66
Impact of QRS complex fragmentation on all-cause mortality before and after cardiac resynchronization therapy	66
Ventriculo-arterial coupling parameters by cardiac magnetic imaging are associated with outcome in patients with a systemic right ventricle	66
Left ventricular early diastolic strain rate and cardiovascular outcome in patients with left ventricular non-compaction phenotype	65
Acute and long-term success of left atrial anterior line and mitral isthmus line ablation in patients after mitral valve surgery	65
Mortality and heart failure in patients with severe tricuspid regurgitation. Impact of RV volumes and function by CMR.	65
Spermidine attenuates left ventricular dysfunction in estrogen deprived aging rats through mitigating lipid peroxidation and mitochondrial dysfunction	65
Disease trajectories following myocardial infarction: insights from process mining of 145 million hospitalisation episodes	65
Results from a nationwide atrial fibrillation screening effort in Belgium	64
Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers	64
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation: an updated systematic review and meta-analysis	64
Dissociation of LA volume and deformation is a hallmark of ATTR-CA	64
Progression, regression and redefining the treatment response – cardiac magnetic resonance with T1 and extracellular volume mapping in cardiac light-chain amyloidosis	63
Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study	63
Impact of proNGF/NGF-NGFR-axis on the regulation of arterial remodelling	63
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis	63
Effects of Sacubitril/Valsartan on all-cause hospitalizations in heart failure: participant-level pooled analysis of PARADIGM-HF and PARAGON-HF	63
Agreement between two independent raters in identifying exercise oscillatory ventilation in patients with heart failure	63
A comparative analysis of conventional echocardiographic findings among different heart failure stages and phenotypes: insights from the national echocardiographic society registry	63
Ten year survival after an acute heart failure episode	62
Spin-lock based magnetic field sensing: a non-invasive MRI method for spatially resolved imaging of cardiac conduction?	62
Pnn deficiency alters expressions of calcium handling proteins and impairs nuclear envelope structure in cardiomyocytes	62
Long-term prognosis after ST-elevation myocardial infarction according to the Canadian Cardiovascular Society classification of tissue injury severity in acute myocardial infarction	62
Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry	62
Routine chest X-ray post cardiac implantable electronic device implantation: is it really required? Experience from a tertiary centre	61
Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate	61
Improving the prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy by adding plasma SVEP1 to conventional clinical model including NT-proBNP	61
Morphology-Voltage-P-wave duration (MVP) score in prediction of incident atrial fibrillation in an elderly epidemiologic cohort	61
Associations of maternal exposure to multiple plasma metals with the risk of fetal congenital heart defects: a prospective nested case-control study	61
Outcomes of chronic total occlussion recanalization in patients with prior bypass-surgery: an updated systematic review and meta-analysis of real world registries	61
The sooner the better? What is the optimal timing for coronary angiography in high-risk non-ST-elevation acute coronary syndrome	60
Myocardial performance index improves prediction of major adverse cardiovascular events and heart failure in type 1 and type 2 diabetes without known heart disease: Thousand&1 and Thousand&2 s	59
Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy	59
Simulating atrial fibrillation patterns and screening strategies using virtual patient-level models	59
Remodeling of adult rat heart subjected to pressure overload from the neonatal period is dependent on the sex	59
Reducing the burden of inconclusive smart-device single-lead ECG tracings via a novel atificial intelligence algorithm	59
Outcomes benefit in asymptomatic patients with moderate aortic valve stenosis followed up in heart valve clinics	58
24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice?	58
Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)	58
Expanding CAD assessment beyond coronary arteries: can body composition offer valuable insights?	58
Activation patterns of intracellular signaling pathways in cardiac hypertrophy induced by different exercise modes in rats	58
Setting the standard: Massimo Piepoli takes on lead editorial role	58
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age	57
Possible mechanistic insights and personalized interventions for sudden cardiac death in diabetes	57
Cardiovascular safety of non-steroidal anti-inflammatory drug use for gout: A Danish nationwide case-crossover study	57
Estrogen-induced phenotype in hiPSC-derived cardiomyocytes of a woman affected by both Long QT Syndrome Type 2 and Polycystic Ovary Syndrome	57
Associations too weak to be useful in screening for cardiovascular disease	57
Comparative effects of ranolazine and trimetazidine on cardiac structure and exercise capacity in a healthy rat model: a new doping agent?	56
Validation of the HFA-ICOS risk assessment tool with real-world data from a prospective cohort of breast cancer patients in treatment with anthracyclines and trastuzumab	56
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance	56
Effectiveness of empagliflozin in patients with heart failure and COPD: Results from EMPEROR-Preserved and EMPEROR-Reduced	56
Immortal Time Bias: the hidden confounder in assessing cardiosurgical treatment effects	56